A citation-based method for searching scientific literature

Hongbing Shen, Meng Zhu, Cheng Wang. NPJ Precis Oncol 2019
Times Cited: 14







List of co-cited articles
33 articles co-cited >1



Times Cited
  Times     Co-cited
Similarity


Global cancer statistics 2018: GLOBOCAN estimates of incidence and mortality worldwide for 36 cancers in 185 countries.
Freddie Bray, Jacques Ferlay, Isabelle Soerjomataram, Rebecca L Siegel, Lindsey A Torre, Ahmedin Jemal. CA Cancer J Clin 2018
28


Estimation of heritability for nine common cancers using data from genome-wide association studies in Chinese population.
Juncheng Dai, Wei Shen, Wanqing Wen, Jiang Chang, Tongmin Wang, Haitao Chen, Guangfu Jin, Hongxia Ma, Chen Wu, Lian Li,[...]. Int J Cancer 2017
39
21

STK11/LKB1 Mutations and PD-1 Inhibitor Resistance in KRAS-Mutant Lung Adenocarcinoma.
Ferdinandos Skoulidis, Michael E Goldberg, Danielle M Greenawalt, Matthew D Hellmann, Mark M Awad, Justin F Gainor, Alexa B Schrock, Ryan J Hartmaier, Sally E Trabucco, Laurie Gay,[...]. Cancer Discov 2018
552
21

The biology and management of non-small cell lung cancer.
Roy S Herbst, Daniel Morgensztern, Chris Boshoff. Nature 2018
21

LKB1/STK11 mutations in non-small cell lung cancer patients: Descriptive analysis and prognostic value.
Francesco Facchinetti, Maria Virginia Bluthgen, Gabrielle Tergemina-Clain, Laura Faivre, Jean-Pierre Pignon, David Planchard, Jordi Remon, Jean-Charles Soria, Ludovic Lacroix, Benjamin Besse. Lung Cancer 2017
51
14

The LKB1-AMPK pathway: metabolism and growth control in tumour suppression.
David B Shackelford, Reuben J Shaw. Nat Rev Cancer 2009
14

Distinct patterns of somatic genome alterations in lung adenocarcinomas and squamous cell carcinomas.
Joshua D Campbell, Anton Alexandrov, Jaegil Kim, Jeremiah Wala, Alice H Berger, Chandra Sekhar Pedamallu, Sachet A Shukla, Guangwu Guo, Angela N Brooks, Bradley A Murray,[...]. Nat Genet 2016
535
14

Suppression of STING Associated with LKB1 Loss in KRAS-Driven Lung Cancer.
Shunsuke Kitajima, Elena Ivanova, Sujuan Guo, Ryohei Yoshida, Marco Campisi, Shriram K Sundararaman, Shoichiro Tange, Yoichiro Mitsuishi, Tran C Thai, Sayuri Masuda,[...]. Cancer Discov 2019
126
14

Molecular Determinants of Response to Anti-Programmed Cell Death (PD)-1 and Anti-Programmed Death-Ligand 1 (PD-L1) Blockade in Patients With Non-Small-Cell Lung Cancer Profiled With Targeted Next-Generation Sequencing.
Hira Rizvi, Francisco Sanchez-Vega, Konnor La, Walid Chatila, Philip Jonsson, Darragh Halpenny, Andrew Plodkowski, Niamh Long, Jennifer L Sauter, Natasha Rekhtman,[...]. J Clin Oncol 2018
639
14

Pembrolizumab versus Chemotherapy for PD-L1-Positive Non-Small-Cell Lung Cancer.
Martin Reck, Delvys Rodríguez-Abreu, Andrew G Robinson, Rina Hui, Tibor Csőszi, Andrea Fülöp, Maya Gottfried, Nir Peled, Ali Tafreshi, Sinead Cuffe,[...]. N Engl J Med 2016
14

Cancer Statistics, 2017.
Rebecca L Siegel, Kimberly D Miller, Ahmedin Jemal. CA Cancer J Clin 2017
14

clusterProfiler: an R package for comparing biological themes among gene clusters.
Guangchuang Yu, Li-Gen Wang, Yanyan Han, Qing-Yu He. OMICS 2012
14

Comprehensive genomic and immunological characterization of Chinese non-small cell lung cancer patients.
Xu-Chao Zhang, Jun Wang, Guo-Guang Shao, Qun Wang, Xiaotao Qu, Bo Wang, Christopher Moy, Yue Fan, Zayed Albertyn, Xiayu Huang,[...]. Nat Commun 2019
79
14

Pembrolizumab versus docetaxel for previously treated, PD-L1-positive, advanced non-small-cell lung cancer (KEYNOTE-010): a randomised controlled trial.
Roy S Herbst, Paul Baas, Dong-Wan Kim, Enriqueta Felip, José L Pérez-Gracia, Ji-Youn Han, Julian Molina, Joo-Hang Kim, Catherine Dubos Arvis, Myung-Ju Ahn,[...]. Lancet 2016
14

Large-scale association analysis identifies new lung cancer susceptibility loci and heterogeneity in genetic susceptibility across histological subtypes.
James D McKay, Rayjean J Hung, Younghun Han, Xuchen Zong, Robert Carreras-Torres, David C Christiani, Neil E Caporaso, Mattias Johansson, Xiangjun Xiao, Yafang Li,[...]. Nat Genet 2017
194
14

An atlas of active enhancers across human cell types and tissues.
Robin Andersson, Claudia Gebhard, Irene Miguel-Escalada, Ilka Hoof, Jette Bornholdt, Mette Boyd, Yun Chen, Xiaobei Zhao, Christian Schmidl, Takahiro Suzuki,[...]. Nature 2014
14

Whole-genome sequencing reveals genomic signatures associated with the inflammatory microenvironments in Chinese NSCLC patients.
Cheng Wang, Rong Yin, Juncheng Dai, Yayun Gu, Shaohua Cui, Hongxia Ma, Zhihong Zhang, Jiaqi Huang, Na Qin, Tao Jiang,[...]. Nat Commun 2018
39
14



Differential association of STK11 and TP53 with KRAS mutation-associated gene expression, proliferation and immune surveillance in lung adenocarcinoma.
M B Schabath, E A Welsh, W J Fulp, L Chen, J K Teer, Z J Thompson, B E Engel, M Xie, A E Berglund, B C Creelan,[...]. Oncogene 2016
129
14

Comprehensive genomic profiling of lung cancer using a validated panel to explore therapeutic targets in East Asian patients.
Liping Liu, Jilong Liu, Di Shao, Qiuhua Deng, Hailing Tang, Zu Liu, Xuewei Chen, Fengming Guo, Yongping Lin, Mao Mao,[...]. Cancer Sci 2017
38
14

Comprehensive Characterization of Oncogenic Drivers in Asian Lung Adenocarcinoma.
Shiyong Li, Yoon-La Choi, Zhuolin Gong, Xiao Liu, Maruja Lira, Zhengyan Kan, Ensel Oh, Jian Wang, Jason C Ting, Xiangsheng Ye,[...]. J Thorac Oncol 2016
49
14

Mutation patterns in a population-based non-small cell lung cancer cohort and prognostic impact of concomitant mutations in KRAS and TP53 or STK11.
Linnéa La Fleur, Elin Falk-Sörqvist, Patrik Smeds, Anders Berglund, Magnus Sundström, Johanna Sm Mattsson, Eva Brandén, Hirsh Koyi, Johan Isaksson, Hans Brunnström,[...]. Lung Cancer 2019
56
14

The 2015 World Health Organization Classification of Lung Tumors: Impact of Genetic, Clinical and Radiologic Advances Since the 2004 Classification.
William D Travis, Elisabeth Brambilla, Andrew G Nicholson, Yasushi Yatabe, John H M Austin, Mary Beth Beasley, Lucian R Chirieac, Sanja Dacic, Edwina Duhig, Douglas B Flieder,[...]. J Thorac Oncol 2015
14

Cancer statistics in China, 2015.
Wanqing Chen, Rongshou Zheng, Peter D Baade, Siwei Zhang, Hongmei Zeng, Freddie Bray, Ahmedin Jemal, Xue Qin Yu, Jie He. CA Cancer J Clin 2016
14

Co-occurring genomic alterations in non-small-cell lung cancer biology and therapy.
Ferdinandos Skoulidis, John V Heymach. Nat Rev Cancer 2019
176
14

Somatic mutations affect key pathways in lung adenocarcinoma.
Li Ding, Gad Getz, David A Wheeler, Elaine R Mardis, Michael D McLellan, Kristian Cibulskis, Carrie Sougnez, Heidi Greulich, Donna M Muzny, Margaret B Morgan,[...]. Nature 2008
14

Lung cancer in never smokers--a different disease.
Sophie Sun, Joan H Schiller, Adi F Gazdar. Nat Rev Cancer 2007
929
14

Tumor mutational load predicts survival after immunotherapy across multiple cancer types.
Robert M Samstein, Chung-Han Lee, Alexander N Shoushtari, Matthew D Hellmann, Ronglai Shen, Yelena Y Janjigian, David A Barron, Ahmet Zehir, Emmet J Jordan, Antonio Omuro,[...]. Nat Genet 2019
14

Global surveillance of trends in cancer survival 2000-14 (CONCORD-3): analysis of individual records for 37 513 025 patients diagnosed with one of 18 cancers from 322 population-based registries in 71 countries.
Claudia Allemani, Tomohiro Matsuda, Veronica Di Carlo, Rhea Harewood, Melissa Matz, Maja Nikšić, Audrey Bonaventure, Mikhail Valkov, Christopher J Johnson, Jacques Estève,[...]. Lancet 2018
14

Next-generation sequencing of non-small cell lung cancer using a customized, targeted sequencing panel: Emphasis on small biopsy and cytology.
David M DiBardino, David W Rawson, Anjali Saqi, Jonas J Heymann, Carlos A Pagan, William A Bulman. Cytojournal 2017
15
14

Molecular Subtypes of Pulmonary Large-cell Neuroendocrine Carcinoma Predict Chemotherapy Treatment Outcome.
Jules L Derks, Noémie Leblay, Erik Thunnissen, Robert Jan van Suylen, Michael den Bakker, Harry J M Groen, Egbert F Smit, Ronald Damhuis, Esther C van den Broek, Amélie Charbrier,[...]. Clin Cancer Res 2018
79
14

Antitumor activity of gambogic acid on NCI-H1993 xenografts via MET signaling pathway downregulation.
Donglei Li, Huiwei Yang, Runpu Li, Yanli Wang, Weijun Wang, Dongjie Li, Shaolin Ma, Xuyu Zhang. Oncol Lett 2015
10
10

LKB1 in lung cancerigenesis: a serine/threonine kinase as tumor suppressor.
Yijun Gao, Gaoxiang Ge, Hongbin Ji. Protein Cell 2011
37
7

Folliculin controls lung alveolar enlargement and epithelial cell survival through E-cadherin, LKB1, and AMPK.
Elena A Goncharova, Dmitry A Goncharov, Melane L James, Elena N Atochina-Vasserman, Victoria Stepanova, Seung-Beom Hong, Hua Li, Linda Gonzales, Masaya Baba, W Marston Linehan,[...]. Cell Rep 2014
59
7

Arenobufagin inhibits prostate cancer epithelial-mesenchymal transition and metastasis by down-regulating β-catenin.
Liping Chen, Weiqian Mai, Minfeng Chen, Jianyang Hu, Zhenjian Zhuo, Xueping Lei, Lijuan Deng, Junshan Liu, Nan Yao, Maohua Huang,[...]. Pharmacol Res 2017
37
7

Novel and natural knockout lung cancer cell lines for the LKB1/STK11 tumor suppressor gene.
Julian Carretero, Pedro P Medina, Ruben Pio, Luis M Montuenga, Montserrat Sanchez-Cespedes. Oncogene 2004
97
7

Acerinol, a cyclolanstane triterpenoid from Cimicifuga acerina, reverses ABCB1-mediated multidrug resistance in HepG2/ADM and MCF-7/ADR cells.
Dao-Lu Liu, Ying-Jie Li, Nan Yao, Jun Xu, Zhe-Sheng Chen, Anita Yiu, Cui-Xian Zhang, Wen-Cai Ye, Dong-Mei Zhang. Eur J Pharmacol 2014
11
9

Gambogic acid induces apoptosis in imatinib-resistant chronic myeloid leukemia cells via inducing proteasome inhibition and caspase-dependent Bcr-Abl downregulation.
Xianping Shi, Xin Chen, Xiaofen Li, Xiaoying Lan, Chong Zhao, Shouting Liu, Hongbiao Huang, Ningning Liu, Siyan Liao, Wenbin Song,[...]. Clin Cancer Res 2014
80
7

Phenformin enhances the therapeutic effect of selumetinib in KRAS-mutant non-small cell lung cancer irrespective of LKB1 status.
Jun Zhang, Sreenivas Nannapaneni, Dongsheng Wang, Fakeng Liu, Xu Wang, Rui Jin, Xiuju Liu, Mohammad Aminur Rahman, Xianghong Peng, Guoqing Qian,[...]. Oncotarget 2017
6
16

Membrane glycomics reveal heterogeneity and quantitative distribution of cell surface sialylation.
Diane Dayoung Park, Gege Xu, Maurice Wong, Chatchai Phoomak, Mingqi Liu, Nathan E Haigh, Sopit Wongkham, Pengyuan Yang, Emanual Maverakis, Carlito B Lebrilla. Chem Sci 2018
23
7

ZEB1 represses E-cadherin and induces an EMT by recruiting the SWI/SNF chromatin-remodeling protein BRG1.
E Sánchez-Tilló, A Lázaro, R Torrent, M Cuatrecasas, E C Vaquero, A Castells, P Engel, A Postigo. Oncogene 2010
294
7

Dysfunctional AMPK activity, signalling through mTOR and survival in response to energetic stress in LKB1-deficient lung cancer.
J Carretero, P P Medina, R Blanco, L Smit, M Tang, G Roncador, L Maestre, E Conde, F Lopez-Rios, H C Clevers,[...]. Oncogene 2007
111
7

Cadherin-mediated cell-cell adhesion and signaling in the skeleton.
Pierre J Marie, Eric Haÿ, Dominique Modrowski, Leila Revollo, Gabriel Mbalaviele, Roberto Civitelli. Calcif Tissue Int 2014
42
7

Ganetespib overcomes resistance to PARP inhibitors in breast cancer by targeting core proteins in the DNA repair machinery.
Juhong Jiang, Yuanzhi Lu, Zhi Li, Liping Li, Daoli Niu, Wenwei Xu, Jing Liu, Lin Fu, Ziqing Zhou, Yingying Gu,[...]. Invest New Drugs 2017
12
8

Hellebrigenin induces cell cycle arrest and apoptosis in human hepatocellular carcinoma HepG2 cells through inhibition of Akt.
Li-Juan Deng, Li-Ping Hu, Qun-Long Peng, Xiao-Lin Yang, Liang-Liang Bai, Anita Yiu, Yong Li, Hai-Yan Tian, Wen-Cai Ye, Dong-Mei Zhang. Chem Biol Interact 2014
24
7

Linking E-cadherin mechanotransduction to cell metabolism through force-mediated activation of AMPK.
Jennifer L Bays, Hannah K Campbell, Christy Heidema, Michael Sebbagh, Kris A DeMali. Nat Cell Biol 2017
89
7

The cadherin superfamily: diversity in form and function.
B D Angst, C Marcozzi, A I Magee. J Cell Sci 2001
422
7

Correlations of the ZEB1 expression with the incidence and prognosis of non-small cell lung cancer.
D-J Ma, H-S Liu, S-Q Li, Y-Z Qin, J He, L Li, Y-S Cui. Eur Rev Med Pharmacol Sci 2019
3
33


Co-cited is the co-citation frequency, indicating how many articles cite the article together with the query article. Similarity is the co-citation as percentage of the times cited of the query article or the article in the search results, whichever is the lowest. These numbers are calculated for the last 100 citations when articles are cited more than 100 times.